Diagnosis, Prediction and Treatment of Neurodegenerative Diseases
A special issue of Sci (ISSN 2413-4155).
Deadline for manuscript submissions: 28 February 2027 | Viewed by 151
Special Issue Editors
Interests: neuroscience; peptides; steroids
Special Issues, Collections and Topics in MDPI journals
Interests: deep brain stimulation; Parkinson’s disease; neurology and neurological rehabilitation; movement disorder
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases represent a growing and challenging burden for society. This because they cause a still unmet sufferance to patients and caregivers, mostly depending on lack of therapies able to guarantee healing or, alternatively, stopping disease progression. Crucial points in combating neurodegenerative diseases are: (i) identification of biomarkers of disease development; (ii) prevention or delay of disease onset; (iii) innovative therapeutic approaches able to stop the disease progression; (iv) effective protocols for rehabilitation to increase the quality of like of patients and caregivers. This special issue is aimed at providing the scientific community with the latest achievements in preclinical and clinical research to improve treatment of neurodegenerative diseases.
Prof. Dr. Giuseppe Biagini
Dr. Francesco Cavallieri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sci is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- amyotrophic lateral sclerosis
- epilepsy
- multiple sclerosis
- Parkinson’s disease
- rare neurodegenerative disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
